TLR9 and acute respiratory distress syndrome: In conclusion, the present findings establish that administration of STING agonists in the airways, besides activating type I IFN response, induces PANoptosis, dsDNA release, and NETosis, leading to neutrophilic lung inflammation and ARDS in a cGAS-independent, TLR9-dependent manner.